A proud lab moment! Earlier this summer, our team published “Exercise and Nutrition in Hematologic Malignancies: Translational Evidence and Emerging Intervention,” co-authored by our recent PhD graduate, Dr. Normann, and our PI, Dr. Dieli-Conwright! ashpublications.org/bloodneoplas...
https://ashpublications.org/bloodneoplasia/article/doi/10.1016/j.bneo.2026.100262/569377/Exercise-and-Nutrition-in-Hematologic-Malignancies
t.co
August 31, 2026 at 1:03 PM
A proud lab moment! Earlier this summer, our team published “Exercise and Nutrition in Hematologic Malignancies: Translational Evidence and Emerging Intervention,” co-authored by our recent PhD graduate, Dr. Normann, and our PI, Dr. Dieli-Conwright! ashpublications.org/bloodneoplas...
Population differences in the associations between chromosomal abnormalities and overall survival of multiple myeloma [Jan 31, 2025] Bei Wang et al. @Bloodneoplasia ashpublications.org/bloodneoplas... #mmsm #PrecisionMedicine #cancerdisparities
March 3, 2025 at 11:06 PM
Population differences in the associations between chromosomal abnormalities and overall survival of multiple myeloma [Jan 31, 2025] Bei Wang et al. @Bloodneoplasia ashpublications.org/bloodneoplas... #mmsm #PrecisionMedicine #cancerdisparities
Minimal residual disease measurement in blood by mass spectrometry identifies long-term responders in multiple myeloma #BloodNeoplasia www.sciencedirect.com/science/arti...
Minimal residual disease measurement in blood by mass spectrometry identifies long-term responders in multiple myeloma
Modern multiple myeloma treatment enables deep and sustained responses, necessitating assessment of minimal residual disease (MRD) in the bone marrow …
www.sciencedirect.com
September 8, 2025 at 6:05 PM
Minimal residual disease measurement in blood by mass spectrometry identifies long-term responders in multiple myeloma #BloodNeoplasia www.sciencedirect.com/science/arti...
Stellar talk from @dasilva-diz.bsky.social in the @herranzlab.bsky.social at #ASH24 presenting her recently accepted paper in #BloodNeoplasia @bloodportfolio.bsky.social @rutgerscancer.bsky.social!! #ProudPI
December 7, 2024 at 12:33 AM
Stellar talk from @dasilva-diz.bsky.social in the @herranzlab.bsky.social at #ASH24 presenting her recently accepted paper in #BloodNeoplasia @bloodportfolio.bsky.social @rutgerscancer.bsky.social!! #ProudPI
Great to have you here! Should we expect your journals to join BlueSky soon too? #Blood #BloodAdvances #BloodNeoplasia
November 22, 2024 at 1:16 AM
Great to have you here! Should we expect your journals to join BlueSky soon too? #Blood #BloodAdvances #BloodNeoplasia
Two multidisciplinary guideline panels prioritized 34 outcomes for 32 research questions related to ALL in AYAs. The prioritized outcomes can inform future primary studies, systematic reviews, and guidelines. Read in Blood Neoplasia: ow.ly/1tJF50YV3e8 #ALL #BloodNeoplasia
May 12, 2026 at 5:15 PM
Two multidisciplinary guideline panels prioritized 34 outcomes for 32 research questions related to ALL in AYAs. The prioritized outcomes can inform future primary studies, systematic reviews, and guidelines. Read in Blood Neoplasia: ow.ly/1tJF50YV3e8 #ALL #BloodNeoplasia
Cobicistat allowed an eightfold reduction in venetoclax while optimizing exposure, demonstrating a cost-effective strategy for AML treatment. Read in Blood Neoplasia: ow.ly/qlzN50YV53A #AML #BloodNeoplasia
May 5, 2026 at 8:20 PM
Cobicistat allowed an eightfold reduction in venetoclax while optimizing exposure, demonstrating a cost-effective strategy for AML treatment. Read in Blood Neoplasia: ow.ly/qlzN50YV53A #AML #BloodNeoplasia
New issue of Blood Neoplasia is out now! Explore here: ashpublications.org/bloodneoplas... #BloodNeoplasia
February 19, 2026 at 4:00 PM
New issue of Blood Neoplasia is out now! Explore here: ashpublications.org/bloodneoplas... #BloodNeoplasia
Explore the latest issue of Blood Neoplasia: ashpublications.org/bloodneoplas... #BloodJournals #BloodNeoplasia #Hemesky
November 25, 2025 at 6:06 PM
Explore the latest issue of Blood Neoplasia: ashpublications.org/bloodneoplas... #BloodJournals #BloodNeoplasia #Hemesky